保乳術(shù)聯(lián)合前哨淋巴結(jié)活檢治療乳腺癌30例臨床療效分析

潘洪濤 閆小軍

[摘要] 目的 乳腺癌是惡性腫瘤疾病的一種，應(yīng)通過有效的手段完成治療，達(dá)到促進(jìn)患者康復(fù)的目的。方法 納入到該院進(jìn)行乳腺癌治療的患者進(jìn)行對(duì)比，方便選取其中的例數(shù)為30例，研究對(duì)象的收集時(shí)間為2018年5月—2019年5月，根據(jù)患者選擇的不同治療方法完成分組，設(shè)置一組為對(duì)照組，采用傳統(tǒng)乳腺癌根治術(shù)治療，另一組為實(shí)驗(yàn)組，采用保乳術(shù)聯(lián)合前哨淋巴結(jié)活檢治療，對(duì)比患者治療結(jié)果。結(jié)果 經(jīng)過對(duì)比，實(shí)驗(yàn)組患者的圍術(shù)期各項(xiàng)指標(biāo)效果顯著[（61.08±9.63）min、（61.62±10.78）mL、（1.23±0.84）d]，差異有統(tǒng)計(jì)學(xué)意義（t=8.624，17.246，4.302，P<0.05）;與對(duì)照組相比，實(shí)驗(yàn)組患者的生活質(zhì)量更高（92.62±9.62）分，差異有統(tǒng)計(jì)學(xué)意義（t=2.594，P=0.015）;將實(shí)驗(yàn)組患者的并發(fā)癥發(fā)生率（0.00%）與對(duì)照組相比顯著較低（26.64%），差異有統(tǒng)計(jì)學(xué)意義（χ2=4.615，P=0.032）。結(jié)論 保乳術(shù)聯(lián)合前哨淋巴結(jié)活檢治療乳腺癌臨床效果較為顯著，值得推廣。

[關(guān)鍵詞] 保乳術(shù);前哨淋巴結(jié)活檢;乳腺癌;傳統(tǒng)乳腺癌根治術(shù);療效

[Abstract] Objective Breast cancer is a kind of malignant tumor disease. Treatment should be completed by effective means to promote the recovery of patients. Methods The patients enrolled in our hospital for breast cancer treatment were compared， and 30 cases were convenient selected. The collection time of the study subjects was 2018.05-2019.05. Grouping was completed according to the different treatment methods selected by the patients， and a group was set as the control group. The patients were treated with traditional radical mastectomy， and the other group was the experimental group. The breast-conserving surgery combined with sentinel lymph node biopsy was used to compare the treatment results of the patients. Results After comparison， the perioperative indicators of the experimental group were significant [（61.08±9.63） min， （61.62±10.78）mL， （1.23±0.84）d]， and the differences were statistically significant （t=8.624，17.246， 4.302， P<0.05）; compared with the control group， the quality of life of patients in the experimental group was higher（92.62±9.62） points， which was statistically significant （t=2.5941， P=0.015）; The incidence of disease （0.00%） was significantly lower than that of the control group（26.64%）， which was statistically significant （χ2=4.615， P=0.032）. Conclusion Breast-conserving surgery combined with sentinel lymph node biopsy has a significant clinical effect on breast cancer， and is worthy of promotion.

[Key words] Breast-conserving surgery; Sentinel lymph node biopsy; Breast cancer; Traditional radical mastectomy; Efficacy

乳腺癌在我國(guó)臨床中發(fā)病率相對(duì)較高，占全身各種惡性腫瘤疾病發(fā)病率的7%～10%之間，是威脅女性生殖健康的重要疾病。近年來，乳腺癌的發(fā)病率逐漸呈上升趨勢(shì)發(fā)展，臨床中常采用外科手術(shù)進(jìn)行治療，傳統(tǒng)的乳腺癌根治術(shù)具有較大的創(chuàng)傷，并且手術(shù)時(shí)間較長(zhǎng)，由此可引發(fā)多種并發(fā)癥的發(fā)生，不利于術(shù)后提高患者的生活質(zhì)量，當(dāng)下臨床中治療乳腺癌不僅在于將疾病徹底根治，同時(shí)需要提高患者的術(shù)后生活質(zhì)量[1]。前哨淋巴結(jié)是乳腺癌向腋窩淋巴結(jié)引流過程中的重要途徑，能夠在手術(shù)過程中避免腋窩血管、淋巴管神經(jīng)受到傷害，同時(shí)能夠降低上肢水腫等多種并發(fā)癥的發(fā)生，保乳聯(lián)合前哨淋巴結(jié)活檢術(shù)在治療乳腺癌過程中，可進(jìn)一步提高患者的生活質(zhì)量[2]。該文從2018年5月—2019年5月的30例乳腺癌患者入手，探究保乳術(shù)聯(lián)合前哨淋巴結(jié)活檢治療療效，現(xiàn)報(bào)道如下。

1? 資料與方法

1.1? 一般資料